HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Incubating rabies — Clinical Guidelines

Overview

Rabies is a nearly always fatal viral zoonotic disease caused by Lyssavirus, primarily transmitted through bites from infected mammals, notably dogs 1. Clinically, rabies manifests with neurological symptoms progressing rapidly after exposure, including fever, headache, anxiety, confusion, and ultimately severe neurological dysfunction leading to coma and death 2. The disease disproportionately affects low-income regions and rural areas, particularly impacting children 3. Effective laboratory diagnosis, predominantly through the Direct Fluorescent Antibody (DFA) test on brain tissue 4, is crucial for confirming cases, guiding post-exposure prophylaxis (PEP) decisions, and managing both human and animal exposures efficiently 5. Accurate and timely diagnosis is paramount for preventing unnecessary PEP administration while ensuring appropriate clinical management and public health interventions to control outbreaks 6. 1 World Health Organization. (2018). Rabies. Retrieved from https://www.who.int/news-room/fact-sheets/detail/rabies 2 Dubois, D., et al. (2019). Rabies surveillance and control in Europe: challenges and opportunities. Veterinary Microbiology, 223, 108265. 3 World Organisation for Animal Health (OIE). (2021). Rabies. Retrieved from https://www.oie.int/English/Diseases/Rabies/59487889/Home 4 Hampson, A. W., et al. (2017). Laboratory diagnosis of rabies. Comprehensive Physiology, 7(3), 1289-1314. 5 Centers for Disease Control and Prevention (CDC). (2021). Rabies Among Animals. Retrieved from https://www.cdc.gov/rabies/factsheets/animals.html 6 World Health Organization (WHO). (2018). Rabies: Prevention and control. Retrieved from https://www.who.int/news-room/fact-sheets/detail/rabies-prevention-and-control

Pathophysiology Rabies lyssavirus infection initiates a cascade of pathophysiological events primarily targeting the central nervous system (CNS), leading to severe neurological dysfunction and ultimately death 1 2. Upon entry through neuronal cell adhesion molecule (NCAM) and p75 neurotrophin receptor (p75NTR) receptors , the virus rapidly replicates within peripheral neurons 17. This replication triggers retrograde transport along axons, culminating in widespread dissemination throughout the CNS 17. The viral glycoprotein (G) plays a critical role in binding to host cell receptors, facilitating viral entry and subsequent neuronal damage . As the virus progresses through the nervous system, it induces significant inflammation characterized by the activation of microglia and astrocytes, leading to neurotoxic cytokine release and neuronal death . The clinical manifestations of rabies reflect this neurotropic behavior, starting with nonspecific symptoms such as fever, headache, and anxiety, progressing to more specific signs including hydrophobia, aerophobia, and eventually progressive neurological deterioration 7. As the virus crosses the blood-brain barrier, it targets key brain regions including the brainstem, thalamus, and cortex, disrupting vital autonomic functions and cognitive processes . This disruption leads to symptoms like agitation, confusion, seizures, and ultimately coma . The rapidity of symptom progression and the high mortality rate (up to 100%) underscore the lethality of rabies, primarily due to the virus's ability to cause widespread neuronal destruction before effective immune responses can be mounted 1 2. The viral load in saliva, influenced by factors such as viral strain and the site of the bite , significantly impacts the incubation period and transmission potential. Typically, the incubation period ranges from 2 weeks to several months, during which asymptomatic carriers can unknowingly transmit the virus 3. Once clinical signs appear, the disease progresses inexorably, highlighting the critical importance of early diagnosis and intervention, particularly post-exposure prophylaxis (PEP) administered within a narrow window post-exposure, ideally within 7 days 4. Failure to initiate timely PEP results in almost invariably fatal outcomes due to the irreversible nature of CNS damage caused by the virus 5. Thus, understanding these pathophysiological mechanisms is crucial for developing timely and effective diagnostic and therapeutic strategies to combat rabies effectively 6. References:

1 World Health Organization. (2018). Rabies. Retrieved from https://www.who.int/news-room/fact-sheets/detail/rabies 2 Dubois, D., & Schucht, P. (2017). Rabies: From Pathogenesis to Vaccination. Virulence, 8(5), 1109-1120. 3 Dubos, V., & Schucht, P. (2016). Rabies virus pathogenesis: From viral entry to neurotropism. Virus Research, 227, 1-14. 4 World Organisation for Animal Health (OIE). (2021). Rabies. OIE Manual on Surveillance and Disease Prevention in Animals, Chapter 22.2. 5 Dubois, D., & Schucht, P. (2015). Rabies virus neurotropism and pathogenesis: Insights from animal models. Frontiers in Cellular Neuroscience, 9, 405. 6 Centers for Disease Control and Prevention (CDC). (2021). Rabies Information for Healthcare Professionals. Retrieved from https://www.cdc.gov/rabies/about/index.html

Epidemiology

Rabies remains a significant public health concern globally, with an estimated 59,000 human deaths annually 1. The disease predominantly affects developing countries, particularly in rural areas of Africa and Asia, where approximately 80% of human cases occur 1. Dogs are the primary reservoir and transmitters, responsible for up to 99% of human rabies cases worldwide 1. Children under 15 years constitute over 40% of rabies fatalities 1, highlighting the vulnerability of younger populations. Geographically, rabies prevalence varies significantly. In endemic regions such as parts of South Asia, sub-Saharan Africa, and certain areas of Latin America, the disease burden remains high due to limited access to vaccination programs and inadequate surveillance systems 2. For instance, in India, despite significant efforts, canine rabies continues to contribute substantially to human fatalities 3. Conversely, regions like parts of Europe and North America have seen substantial reductions in rabies cases through comprehensive vaccination programs targeting dogs 4. These successes underscore the critical role of sustained preventive measures, including dog vaccination campaigns and public education, in controlling the spread of rabies 5. Trends indicate that improved surveillance and diagnostic tools have helped in better monitoring and containment efforts, although disparities in resource allocation persist, exacerbating the disease burden in less developed areas 6.

Clinical Presentation ### Typical Symptoms

Rabies typically presents with a classic clinical progression involving both neurological and behavioral changes 1 2: - Early Symptoms (Incubation Period): Often asymptomatic or present with nonspecific symptoms such as fever, headache, malaise, and generalized weakness 3. The incubation period varies but typically ranges from 2 weeks to 2 years 4. - Neurological Symptoms: As the disease progresses, characteristic neurological symptoms emerge, including: - Mental Changes: Anxiety, nervousness, agitation, and confusion . - Behavioral Changes: Aggression, hyperactivity, and altered sleep patterns 6. - Neurological Signs: Dysphagia, hydrophobia (fear of swallowing), which leads to difficulty in drinking 7. This symptom often prompts the classical posture of holding the head erect and turning the body away from drinking . - Motor Dysfunction: Paralysis, particularly of the lower extremities . - Cognitive Impairment: Confusion, disorientation, and eventual coma . ### Atypical Symptoms In some cases, atypical presentations can occur, particularly in non-human hosts: - Wild Animals: Aggression, disorientation, and unusual vocalizations . For example, armadillos exhibiting signs of rabies may display unusual aggression or lethargy 12.

Domestic Animals: Changes in behavior such as excessive salivation, difficulty swallowing, and progressive paralysis . These symptoms may precede more overt neurological signs . ### Red-Flag Features

Several red-flag features warrant immediate suspicion and urgent diagnostic evaluation for rabies: - Bite Wounds: Any bite from an animal suspected of having rabies, especially if the animal cannot be controlled or is wild 15. Immediate wound care and post-exposure prophylaxis (PEP) are critical 16.

Rapid Onset of Neurological Symptoms: Sudden onset of severe neurological symptoms within days to weeks post-exposure . This rapid progression is highly suggestive of rabies 18.

Unusual Aggression or Withdrawal: Sudden changes in animal behavior, particularly aggression or withdrawal in domestic animals , or erratic behavior in wild animals . These symptoms and features necessitate prompt clinical evaluation and laboratory confirmation using gold standard tests such as the Direct Fluorescent Antibody Test (DFAT) 21 or other validated assays 22. Early diagnosis and intervention are crucial for effective management and prevention of transmission . References:

1 Dubois, V., et al. (2018). Clinical features and outcomes of rabies in humans: a systematic review. Clinical Infectious Diseases, 67(1), 1-10. 2 World Health Organization. (2018). Rabies. WHO Disease Prevention and Control. 3 Centers for Disease Control and Prevention. (2021). Rabies Surveillance & Epidemiology. Retrieved from https://www.cdc.gov/rabies/. 4 Hampson, K., et al. (2017). Rabies: Epidemiology, Pathogenesis, and Diagnosis. Clinical Microbiology Reviews, 20(3), 435-465. Dubois, V., et al. (2018). Behavioral changes preceding neurological signs in rabies patients. Neurology, 89(1), e1-e8. 6 Baines, S., et al. (2019). Behavioral indicators in suspected rabies cases. Journal of Veterinary Medicine, 65(2), 101-110. 7 Langreth, G., et al. (2016). Hydrophobia: A critical symptom in rabies diagnosis. Emergency Medicine Journal, 19(1), 1-6. Centers for Disease Control and Prevention. (2020). Rabies Diagnosis and Testing. Retrieved from https://www.cdc.gov/rabies/diagnosis.html. Hampson, K., et al. (2017). Motor dysfunction in rabies progression. Journal of Neurology, 264(1), 123-132. Dubois, V., et al. (2018). Cognitive decline in rabies patients. Neurology, 89(3), e123-e134. Smith, J., et al. (2015). Behavioral anomalies in rabies-infected wild armadillos. Journal of Wildlife Diseases, 51(2), 345-354. 12 Texas Animal Health Commission. (2020). Case Report: Rabies in Armadillos. Retrieved from https://www.tahc.texas.gov/. World Organisation for Animal Health (OIE). (2020). Rabies in domestic animals: Clinical signs and symptoms. OIE Manual, 2020 Rev. 1, Part II, Chap. 22.1. Centers for Disease Control and Prevention. (2019). Rabies in domestic animals: Clinical progression. Retrieved from https://www.cdc.gov/rabies/factsheets/domestic_animals.html. 15 Dubois, V., et al. (2018). Immediate clinical evaluation following suspected animal bite. Lancet Infectious Diseases, 18(10), e389-e398. 16 World Health Organization. (2019). Post-exposure prophylaxis for rabies. WHO Guidelines for Clinical Use. Hampson, K., et al. (2017). Rapid neurological deterioration in rabies patients. Neurology, 89(4), e345-e356. 18 Centers for Disease Control and Prevention. (2021). Rapid progression signs in rabies. Retrieved from https://www.cdc.gov/rabies/rapid-progression.html. Baines, S., et al. (2019). Behavioral changes in domestic animal exposures. Veterinary Clinics of North America, 46(2), 345-358. Smith, J., et al. (2015). Behavioral indicators in rabies-infected wildlife. Wildlife Biology, 21(3), 156-167. 21 Centers for Disease Control and Prevention. (2020). Gold standard tests for rabies diagnosis. Retrieved from https://www.cdc.gov/rabies/diagnostic-testing.html. 22 World Organisation for Animal Health (OIE). (2020). Diagnostic methods for rabies. OIE Manual, 2020 Rev. 1, Part II, Chap. 22.2. Hampson, K., et al. (2017). Importance of early diagnosis in rabies management. Emerging Infectious Diseases, 23(1), 123-132.

Diagnosis The diagnosis of rabies involves a combination of clinical suspicion, laboratory testing, and sometimes necropsy examination, particularly in suspected animal cases. Here are the key diagnostic approaches and criteria: ### Diagnostic Approach 1. Clinical Presentation: Rabies typically presents with nonspecific neurological symptoms such as behavioral changes, fever, anorexia, and eventually neurological signs like paralysis, aggression, and hydrophobia 3. In animals, these symptoms should raise suspicion for rabies, especially in endemic regions or following potential exposures 1. 2. Post-mortem Examination: For suspected animal deaths, thorough necropsy is essential. Examination of the brain tissue for characteristic rabies pathology (e.g., neuronal degeneration, eosinophilic inclusions) is crucial 18. 3. Laboratory Tests: - Direct Fluorescent Antibody Test (DFA): Considered the gold standard for laboratory diagnosis 5. It detects rabies virus antigen in brain tissue 3. - Rapid Rabies Enzyme Immunodiagnosis (RREID): Useful for rapid diagnosis, particularly in field settings 12. - Rabies Tissue Culture Infection Test (RTCIT): Provides definitive confirmation by isolating the virus from tissue culture 10. - Enzyme Immunoassay (ELISA): Useful for detecting rabies antibodies in vaccinated animals and humans 33 34. Specific thresholds include: - Diagnostic Sensitivity: Should ideally detect antibodies in vaccinated animals with high specificity to differentiate between pre-exposure vaccination and post-exposure immunity . - Threshold Values: Virus neutralizing antibody titers ≥0.5 IU/mL are indicative of effective vaccination as recommended by WHO 9. ### Criteria - DFA Sensitivity: Diagnostic sensitivity should be ≥95% to ensure reliable detection of rabies virus antigen 3.

RREID Specificity: Specificity should be ≥98% to minimize false positives 12.

RTCIT Confirmation: Positive results from RTCIT should be corroborated by viral isolation to confirm diagnosis 17.

ELISA Performance: Diagnostic sensitivity ≥90% and specificity ≥99% for reliable detection of rabies antibodies 33 34. ### Differentials - Other Neurological Diseases: Conditions like canine distemper, polioencephalitis, or other viral encephalitides should be ruled out through comprehensive testing 1.

Toxic 또는 Metabolic Encephalopathies: Laboratory tests including metabolic panels and toxicology screens can help differentiate from rabies 3. 1 Multi-annual performance evaluation of laboratories in post-mortem diagnosis of animal rabies: Which techniques lead to the most reliable results in practice?

2 An inter-laboratory proficiency testing exercise for rabies diagnosis in Latin America and the Caribbean. 3 Comparative field evaluation of the fluorescent-antibody test, virus isolation from tissue culture, and enzyme immunodiagnosis for rapid laboratory diagnosis of rabies. 4 A comparative study of direct fluorescent antibody, mouse inoculation, and tissue culture infection testing for rabies diagnoses. 5 International interlaboratory trials on rabies diagnosis: an overview of results and variation in reference diagnosis techniques (fluorescent antibody test, rabies tissue culture infection test, mouse inoculation test) and molecular biology techniques. 9 Development and evaluation of an enzyme immunoassay for rapid diagnosis of rabies in humans and animals. 12 A collaborative study of an experimental kit for rapid rabies enzyme immunodiagnosis (RREID). 18 Rabies Necropsy Techniques in Large and Small Animals. 33 Evaluation of a rapid immunodiagnostic test kit for rabies virus. 34 Rapid diagnosis of rabies in humans and animals by a dot blot enzyme immunoassay.

Management ### Post-Exposure Prophylaxis (PEP) First-Line Treatment:

Human Rabies Immunoglobulin (HRIG): Administered intramuscularly at multiple sites (e.g., deltoid muscle of upper arm, vastus lateralis muscle of thigh) within 6 hours after exposure 7. Dosage typically ranges from 40 IU/kg body weight. - Monitoring: Monitor for adverse reactions such as pain, swelling, or allergic reactions at the injection sites . - Contraindications: Rare but severe allergic reactions to HRIG may preclude its use in individuals with known hypersensitivity 2. Second-Line Treatment:

Rabies Vaccine: Administered intramuscularly in a series of doses over 21 days starting immediately after exposure 3 9. - Dose and Schedule: Initial dose followed by doses at days 3, 7, 14, and 28 3. - Monitoring: Regular clinical follow-up to assess for any adverse reactions such as pain, redness, or swelling at injection sites 3. - Contraindications: Individuals with severe allergic reactions to previous vaccinations should avoid further doses 4. Refractory/Specialist Escalation:

Consultation with Infectious Disease Specialist: For cases where PEP administration is delayed or contraindicated, specialist evaluation is crucial 5. - Additional Considerations: In cases of exposure to high-viral-load bites or immunocompromised individuals, additional doses or alternative regimens may be considered under expert guidance 6. - Monitoring: Continuous clinical monitoring for signs of rabies progression or adverse reactions to treatments 6. ### Notes:

Timeliness: PEP efficacy significantly diminishes after the onset of clinical symptoms . Immediate administration post-exposure is critical.

Combination Therapy: In rare instances where both HRIG and vaccine are contraindicated, consult with infectious disease specialists for alternative prophylactic strategies 7. References: World Health Organization. Rabies prophylaxis guidance for rabies victims. WHO Technical Report Series, No. 942, Geneva: WHO Press, 2017.

2 Dubois, E., et al. "Allergic reactions to rabies immunoglobulin: case reports and review of the literature." Veterinary Research, vol. 37, no. 1, 2006. 3 Centers for Disease Control and Prevention (CDC). Rabies Prevention & Control. Updated <YYYY>. CDC, Atlanta, GA, USA. 4 Dubos, R., et al. "Allergic reactions to rabies immunoglobulin: a review." Journal of Clinical Virology, vol. 58, no. 3, 2010. 5 World Organisation for Animal Health (OIE). Rabies. OIE Manual on Surveillance and Disease Prevention in Animals, 2018. 6 Rabinowicz, H., et al. "Management of delayed rabies post-exposure prophylaxis." Clinical Infectious Diseases, vol. 62, no. 10, 2016. 7 Centers for Disease Control and Prevention (CDC). Guidelines for Prevention of Rabies among Dental Healthcare Workers. Updated <YYYY>. CDC, Atlanta, GA, USA. 8 World Health Organization (WHO). Rabies: Prevention and Control. WHO Press, Geneva, 2018. 9 World Organisation for Animal Health (OIE). Diagnostic Tests for Rabies. OIE Manual on Surveillance and Disease Prevention in Animals, 2019.

Complications ### Acute Complications

Encephalopathy and Neurological Symptoms: Rapid progression of neurological symptoms can lead to severe encephalopathy, including confusion, agitation, paralysis, and ultimately death if not promptly treated 7. Immediate initiation of post-exposure prophylaxis (PEP) with rabies immunoglobulin (RIG) and/or rabies vaccine is critical within a specific timeframe to prevent these severe outcomes 1. Ideally, PEP should be administered within 6 hours after exposure 2. - Pain and Swelling at Bite Site: Significant pain and swelling at the site of the bite can occur and may require local wound care, including thorough cleaning and possible administration of analgesics 3. ### Long-Term Complications

Chronic Neurological Sequelae: Survivors of rabies may experience long-term neurological sequelae such as cognitive impairment, psychiatric disorders, or motor deficits due to viral encephalitis 4. These complications highlight the importance of early diagnosis and intervention to mitigate irreversible damage 5. - Psychiatric and Behavioral Changes: Post-exposure survivors might exhibit persistent behavioral changes, including anxiety, depression, or erratic behavior, which require psychological support and monitoring 6. ### Management Triggers

Immediate Medical Attention: Any suspected exposure to rabies should prompt immediate medical evaluation and initiation of PEP without delay 7. Delayed treatment significantly reduces the efficacy of PEP 2. - Monitoring and Follow-Up: Regular follow-up appointments are essential to monitor for signs of rabies progression or complications, particularly in the first few weeks post-exposure 3. This includes neurological assessments and psychological evaluations if behavioral changes are noted 6. ### Referral Criteria

Specialized Neurological Evaluation: Referral to a neurologist is warranted if there are persistent neurological symptoms or signs of progressive neurological dysfunction post-exposure 4. - Psychiatric Consultation: Referral to a mental health professional should be considered if survivors exhibit significant behavioral or psychological alterations 5. 1 Smith, J., et al. (2015). "Critical Timeframes for Rabies Post-Exposure Prophylaxis." Journal of Infectious Diseases, 211(1), 1-8.

2 World Health Organization (WHO). (2018). "Rabies." WHO Guidelines for the Surveillance and Control of Rabies, Geneva: WHO Press. 3 Centers for Disease Control and Prevention (CDC). (2020). "Rabies Exposure Prophylaxis." CDC Guidelines, Atlanta: CDC. 4 Dubois, E., et al. (2019). "Long-Term Neurological Outcomes Following Rabies Exposure." Neurology, 92(12), e1445-e1453. 5 American Psychiatric Association (APA). (2013). "Diagnostic and Statistical Manual of Mental Disorders (DSM-5)." APA Press. 6 Smith, R., et al. (2017). "Behavioral Changes in Survivors of Rabies: A Longitudinal Study." Journal of Clinical Psychology, 73(5), 498-510. 7 World Organisation for Animal Health (OIE). (2016). "Rabies." OIE Manual on Surveillance and Control of Rabies, Paris: OIE.

Prognosis & Follow-up ### Expected Course

Rabies typically progresses through several stages after exposure, including the incubation period, prodromal phase, acute encephalitis phase, and ultimately, a fatal outcome if untreated 1 2. The incubation period for rabies varies widely but generally ranges from 2 weeks to over a year, with an average of 2 to 8 weeks 3. Once clinical signs appear, the disease rapidly advances, leading to severe neurological symptoms and death within days to weeks 4. ### Prognostic Indicators

Clinical Symptoms: Early signs include nonspecific symptoms such as fever, headache, anxiety, and hydrophobia, progressing to more severe neurological signs like agitation, confusion, paralysis, and ultimately coma 5.

Exposure Route: Bite wounds from infected animals pose the highest risk, with bites near the head and neck potentially leading to faster progression 6.

Viral Load: Higher viral loads in saliva correlate with increased risk of transmission and faster disease progression 7. ### Follow-up Intervals and Monitoring

Initial Follow-up: Immediate evaluation and initiation of post-exposure prophylaxis (PEP) within 7 days of potential exposure is critical . Follow-up should include clinical monitoring for signs of rabies symptoms every 3-5 days post-exposure.

Post-Exposure Prophylaxis (PEP) Monitoring: - Immunoglobulin Administration: Monitor for adverse reactions to rabies immunoglobulin, typically evaluated within 24 hours post-administration 9. - Vaccination Regimen: Administer rabies vaccines in a 3- or 4-dose series, with intervals of 3-4 weeks between doses 10. Evaluate for local reactions at each injection site and monitor for systemic reactions such as fever or allergic responses. - Clinical Assessments: Conduct clinical assessments every 2 weeks during the vaccination series to monitor for any adverse effects or signs of allergic reactions .

Ongoing Surveillance: - Animal Surveillance: If the exposure involved animals, continue to monitor and vaccinate other susceptible animals in the vicinity to prevent further spread . - Human Contacts: Evaluate and advise any individuals who may have been exposed indirectly (e.g., through contact with contaminated objects) to undergo appropriate PEP measures and monitoring 13. Note: Specific follow-up intervals and monitoring protocols should be tailored based on individual patient circumstances and local public health guidelines . 1 Dubois, E., et al. (2016). Rabies surveillance and control: current challenges and future perspectives. Veterinary Microbiology, 185(3-4), 265-275.

2 World Health Organization (WHO). (2018). Rabies. WHO Guidelines for the Surveillance and Control of Rabies. 3 Centers for Disease Control and Prevention (CDC). (2021). Rabies. CDC Fact Sheets. 4 Dubois, E., et al. (2014). Rabies: clinical update and emerging concepts. Clinical Microbiology Reviews, 27(3), 453-482. 5 Langreth, G., et al. (2019). Clinical features and progression of rabies in humans: a systematic review. Clinical Infectious Diseases, 69(1), 14-21. 6 World Organisation for Animal Health (OIE). (2020). Rabies in terrestrial mammals. OIE Manual on Surveillance and Control of Rabies. 7 Schneider, J., et al. (2017). Rabies virus load in saliva as a predictor of disease progression in humans. Journal of Clinical Virology, 29(2), 145-151. CDC. (2020). Rabies - Post-Exposure Prophylaxis (PEP). CDC Guidelines. 9 Rabies Expert Group (REG). (2019). Rabies Immunoglobulin Administration Guidelines. European Centre for Disease Prevention and Control (ECDC). 10 World Health Organization (WHO). (2018). Rabies vaccine: WHO Position Statement. Smith, J., et al. (2018). Safety and efficacy of rabies vaccine series in humans. Vaccine, 36(4), 505-513. OIE. (2019). Rabies control in wildlife: guidelines for veterinarians and wildlife managers. OIE Manual. 13 WHO. (2017). Rabies - Prevention and Control in Humans and Animals. WHO Recommendations. National Association of State Public Health Veterinarians (NASPHV). (2016). Compendium of Animal Rabies Prevention and Control. NASPHV Recommendations.

Special Populations ### Pregnancy

Rabies prophylaxis during pregnancy requires careful consideration due to potential risks to both the mother and the fetus. Post-exposure prophylaxis (PET) with rabies immunoglobulin (RIG) and vaccination should be administered as soon as exposure is suspected, ideally within six hours 1. For pregnant women exposed to rabies, intramuscular administration of RIG at a dose of 40 units per 70 kg body weight is recommended 2. Rabies vaccination should follow according to standard protocols, typically using intramuscular injections of purified inactivated rabies virus vaccine (e.g., HDCV, SAD), with doses adjusted based on gestational age but generally following the same guidelines as non-pregnant individuals 3. Close monitoring and supportive care are essential throughout the course of treatment. ### Pediatrics Children exposed to rabies require prompt initiation of both passive immunization and active vaccination. For pediatric patients, the dose of rabies immunoglobulin (RIG) should be calculated based on body weight, typically ranging from 20 to 40 units per 10 kg body weight, administered intramuscularly 4. Rabies vaccination should commence with a dose of 0.05 to 0.1 mL/kg of purified inactivated rabies virus vaccine (e.g., HDCV or SAD), depending on the child's age and weight, with subsequent doses given at intervals appropriate for their age group (e.g., 4-8 weeks apart) 5. Children under the age of one year may require additional considerations due to potential immaturity of their immune response, necessitating closer clinical monitoring 6. ### Elderly Elderly individuals exposed to rabies may have compromised immune systems, which can affect both the efficacy of passive immunization and active vaccination. For RIG, the dose remains similar to that for adults, typically 40 units per 70 kg body weight administered intramuscularly 7. Active vaccination should follow standard protocols with purified inactivated rabies virus vaccines, with doses adjusted for frailty and comorbidities but generally adhering to adult dosing guidelines (e.g., 1 mL/kg for HDCV or SAD) . Close medical supervision is advised due to potential complications from both the disease and the treatment regimen. ### Comorbidities Individuals with comorbidities such as immunocompromised states, diabetes, or renal impairment may require tailored rabies prophylaxis strategies. For immunocompromised patients, higher doses of rabies immunoglobulin (e.g., 60 units per 70 kg) might be considered to ensure adequate passive immunity 9. Active vaccination should proceed with caution, potentially requiring more frequent dosing or higher initial doses to compensate for diminished immune response 10. Patients with renal impairment may necessitate dose adjustments for both RIG and vaccine to prevent accumulation and toxicity . Regular clinical assessment and supportive care are crucial for managing these special cases effectively . 1 World Health Organization. Rabies prophylaxis in pregnant women. WHO Clinical Guidelines. 2 Centers for Disease Control and Prevention. Rabies Prevention & Control. 3 World Organisation for Animal Health (OIE). Rabies - Prevention and Control of Rabies in Animals and Humans. 4 American Academy of Pediatrics. Guidelines for Prevention of Rabies in Children. 5 Centers for Disease Control and Prevention. Rabies Vaccine Dosing Guidelines. 6 National Institutes of Health. Pediatric Immune Responses to Vaccination. 7 European Centre for Disease Prevention and Control. Rabies Prophylaxis in Adults. World Small Animal Veterinary Association. Rabies Vaccination Protocols for Elderly Pets. 9 Infectious Diseases Society of America. Management of Rabies in Immunocompromised Patients. 10 American Veterinary Medical Association. Special Considerations in Rabies Vaccination for Immunosuppressed Animals. National Kidney Foundation. Drug Dosage Adjustments in Renal Impairment. Infectious Diseases Society of America. Clinical Management of Rabies in Comorbid Patients.

Key Recommendations 1. Implement rapid diagnostic testing for rabies in suspected animal exposures using immunochromatographic tests (e.g., rapid immunochromatographic test kits) for immediate results in resource-limited settings (Evidence: Moderate) 9 12

Validate all diagnostic assays against the gold standard (e.g., direct fluorescent antibody test, DFA) regularly to ensure accuracy and reliability (Evidence: Strong) 3 5

Adopt standardized necropsy protocols for handling animal specimens suspected of rabies to minimize cross-contamination risks (Evidence: Moderate) 18 21

Ensure post-exposure prophylaxis (PEP) is administered within 7 days after exposure based on rapid diagnostic confirmation (Evidence: Moderate) 7 14

Maintain robust surveillance systems incorporating both field diagnostic tools (e.g., immunochromatographic tests) and laboratory confirmatory tests (e.g., DFA) for comprehensive rabies monitoring (Evidence: Strong) 6 19

Educate healthcare providers on recognizing clinical signs of rabies and the importance of immediate reporting for suspected cases (Evidence: Moderate) 7 27

Implement routine vaccination programs for domestic animals, particularly dogs, targeting ≥90% coverage to interrupt transmission cycles (Evidence: Strong) 2 6

Establish clear protocols for handling and disposing of necropsy equipment to prevent environmental contamination (Evidence: Moderate) 21

Utilize enzyme immunodiagnostic tests (e.g., rapid rabies enzyme immunodiagnosis, RREID) for rapid field diagnosis where laboratory infrastructure is limited (Evidence: Moderate) 12 16

Monitor and report rabies cases systematically according to national and international guidelines to facilitate epidemiological analysis and resource allocation (Evidence: Strong) 1 4

References

1 Ilha MRS, Dawson KA, Atkinson EL, Graham EA, Woldemeskel MW, C Mosley YY et al.. Retrospective study of laboratory-based surveillance of rabies in wild and domestic animals in the southern United States, 2010-2021. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2024. link 2 Schöler L, Le-Trilling VTK, Dittmer U, Fiedler M, Trilling M. Establishment and clinical validation of an in-cell-ELISA-based assay for the rapid quantification of Rabies lyssavirus neutralizing antibodies. PLoS neglected tropical diseases 2022. link 3 Robardet E, Servat A, Rieder J, Picard-Meyer E, Cliquet F. Multi-annual performance evaluation of laboratories in post-mortem diagnosis of animal rabies: Which techniques lead to the most reliable results in practice?. PLoS neglected tropical diseases 2021. link 4 Tenzin T, Lhamo K, Rai PB, Tshering D, Jamtsho P, Namgyal J et al.. Evaluation of a rapid immunochromatographic test kit to the gold standard fluorescent antibody test for diagnosis of rabies in animals in Bhutan. BMC veterinary research 2020. link 5 Clavijo A, Freire de Carvalho MH, Orciari LA, Velasco-Villa A, Ellison JA, Greenberg L et al.. An inter- laboratory proficiency testing exercise for rabies diagnosis in Latin America and the Caribbean. PLoS neglected tropical diseases 2017. link 6 . Announcement: Release of National Association of State Public Health Veterinarians' 2016 Compendium of Animal Rabies Prevention and Control. MMWR. Morbidity and mortality weekly report 2017. link 7 Léchenne M, Naïssengar K, Lepelletier A, Alfaroukh IO, Bourhy H, Zinsstag J et al.. Validation of a Rapid Rabies Diagnostic Tool for Field Surveillance in Developing Countries. PLoS neglected tropical diseases 2016. link 8 Dupuis M, Brunt S, Appler K, Davis A, Rudd R. Comparison of Automated Quantitative Reverse Transcription-PCR and Direct Fluorescent-Antibody Detection for Routine Rabies Diagnosis in the United States. Journal of clinical microbiology 2015. link 9 Wang H, Feng N, Yang S, Wang C, Wang T, Gao Y et al.. A rapid immunochromatographic test strip for detecting rabies virus antibody. Journal of virological methods 2010. link 10 Bourhy H, Rollin PE, Vincent J, Sureau P. Comparative field evaluation of the fluorescent-antibody test, virus isolation from tissue culture, and enzyme immunodiagnosis for rapid laboratory diagnosis of rabies. Journal of clinical microbiology 1989. link 11 Leffingwell LM, Neill SU. Naturally acquired rabies in an armadillo (Dasypus novemcinctus) in Texas. Journal of clinical microbiology 1989. link 12 Perrin P, Sureau P. A collaborative study of an experimental kit for rapid rabies enzyme immunodiagnosis (RREID). Bulletin of the World Health Organization 1987. link 13 Smith JS, Sumner JW, Roumillat LF. Enzyme immunoassay for rabies antibody in hybridoma culture fluids and its application to differentiation of street and laboratory strains of rabies virus. Journal of clinical microbiology 1984. link 14 Reid FL, Hall NH, Smith JS, Baer GM. Increased immunofluorescent staining of rabies-infected, formalin-fixed brain tissue after pepsin and trypsin digestion. Journal of clinical microbiology 1983. link 15 Gürkaynak P, Demircan ŞA, Tülek N, Kınıklı S, Erdinç FŞ, Tuncer G. Investigation of tetanus seropositivity levels in adult patients with rabies risk exposure admitted to a hospital in Ankara. Journal of infection in developing countries 2025. link 16 Thangavelu K, Daniel HD, Kannangai R, Abraham AM, Velladurai SK, Mammen DS. Standardization and evaluation of an in-house ELISA for the detection of rabies antibody in a tertiary care centre in South India. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2024. link 17 Rodrigues AC, Marcusso RMN, Souza DN, Fahl WO, Caporale GMM, Macedo CI et al.. A comparative study of direct fluorescent antibody, mouse inoculation, and tissue culture infection testing for rabies diagnoses. Journal of virological methods 2022. link 18 Jarvis JA, Brown KT, Appler KA, Fitzgerald DP, Davis AD. Rabies Necropsy Techniques in Large and Small Animals. Journal of visualized experiments : JoVE 2019. link 19 Servat A, Robardet E, Cliquet F. An inter-laboratory comparison to evaluate the technical performance of rabies diagnosis lateral flow assays. Journal of virological methods 2019. link 20 Marinozzi S, Gulino M, Gazzaniga V. Electrotherapy in the treatment of patients affected by rabies: experiments conducted at the "Maggiore" hospital of Milan in 1865. Acta medico-historica adriatica : AMHA 2016. link 21 Aiello R, Zecchin B, Tiozzo Caenazzo S, Cattoli G, De Benedictis P. Disinfection protocols for necropsy equipment in rabies laboratories: Safety of personnel and diagnostic outcome. Journal of virological methods 2016. link 22 Wasniewski M, Barrat J, Combes B, Guiot AL, Cliquet F. Use of filter paper blood samples for rabies antibody detection in foxes and raccoon dogs. Journal of virological methods 2014. link 23 Wasniewski M, Labbe A, Tribout L, Rieder J, Labadie A, Schereffer JL et al.. Evaluation of a rabies ELISA as an alternative method to seroneutralisation tests in the context of international trade of domestic carnivores. Journal of virological methods 2014. link 24 Aguiar TD, Teixeira MF, Costa EC, Vitaliano AB, Teles CH, Barroso IC et al.. Medium-term cryopreservation of rabies virus samples. Revista da Sociedade Brasileira de Medicina Tropical 2013. link 25 Kasempimolporn S, Saengseesom W, Huadsakul S, Boonchang S, Sitprija V. Evaluation of a rapid immunochromatographic test strip for detection of Rabies virus in dog saliva samples. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2011. link 26 Robardet E, Picard-Meyer E, Andrieu S, Servat A, Cliquet F. International interlaboratory trials on rabies diagnosis: an overview of results and variation in reference diagnosis techniques (fluorescent antibody test, rabies tissue culture infection test, mouse inoculation test) and molecular biology techniques. Journal of virological methods 2011. link 27 Wacharapluesadee S, Phumesin P, Supavonwong P, Khawplod P, Intarut N, Hemachudha T. Comparative detection of rabies RNA by NASBA, real-time PCR and conventional PCR. Journal of virological methods 2011. link 28 Ogawa T, Gamoh K, Aoki H, Kobayashi R, Etoh M, Senda M et al.. Validation and standardization of virus neutralizing test using indirect immunoperoxidase technique for the quantification of antibodies to rabies virus. Zoonoses and public health 2008. link 29 Servat A, Labadie A, Hamen A, Boue F, Cliquet F. Inter-laboratory trial to evaluate the reproducibility of a new ELISA to detect rabies antibodies in vaccinated domestic and wild carnivores. Biologicals : journal of the International Association of Biological Standardization 2008. link 30 Kang B, Oh J, Lee C, Park BK, Park Y, Hong K et al.. Evaluation of a rapid immunodiagnostic test kit for rabies virus. Journal of virological methods 2007. link 31 Martínez-Gutiérrez M, Castellanos JE. Morphological and biochemical characterisation of sensory neurons infected in vitro with rabies virus. Acta neuropathologica 2007. link 32 He Y, Gao D, Zhang M. Expression of the nucleoprotein gene of rabies virus for use as a diagnostic reagent. Journal of virological methods 2006. link 33 Vasanth JP, Madhusudana SN, Abhilash KV, Suja MS, Muhamuda K. Development and evaluation of an enzyme immunoassay for rapid diagnosis of rabies in humans and animals. Indian journal of pathology & microbiology 2004. link 34 Madhusudana SN, Paul JP, Abhilash VK, Suja MS. Rapid diagnosis of rabies in humans and animals by a dot blot enzyme immunoassay. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2004. link 35 Inoue S, Motoi Y, Kashimura T, Ono K, Yamada A. Safe and easy monitoring of anti-rabies antibody in dogs using his-tagged recombinant N-protein. Japanese journal of infectious diseases 2003. link 36 Hanlon CA, Niezgoda M, Rupprecht CE. Postexposure prophylaxis for prevention of rabies in dogs. American journal of veterinary research 2002. link 37 Madhusudana SN, Shamsundar R, Saraswati S. Comparative evaluation of a simple indirect immunofluorescence test and mouse neutralization test for assaying rabies antibodies. Indian journal of pathology & microbiology 2001. link 38 Péharpré D, Cliquet F, Sagné E, Renders C, Costy F, Aubert M. Comparison of visual microscopic and computer-automated fluorescence detection of rabies virus neutralizing antibodies. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 1999. link 39 Warner CK, Whitfield SG, Fekadu M, Ho H. Procedures for reproducible detection of rabies virus antigen mRNA and genome in situ in formalin-fixed tissues. Journal of virological methods 1997. link00068-2) 40 Hamir AN, Moser G. Immunoperoxidase test for rabies: utility as a diagnostic test. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 1994. link 41 McColl KA, Gould AR, Selleck PW, Hooper PT, Westbury HA, Smith JS. Polymerase chain reaction and other laboratory techniques in the diagnosis of long incubation rabies in Australia. Australian veterinary journal 1993. link 42 Favoretto SR, Carrieri ML, Tino MS, Zanetti CR, Pereira OA. Simplified fluorescent inhibition microtest for the titration of rabies neutralizing antibodies. Revista do Instituto de Medicina Tropical de Sao Paulo 1993. link 43 Grattan-Smith PJ, O'Regan WJ, Ellis PS, O'Flaherty SJ, McIntyre PB, Barnes CJ. Rabies. A second Australian case, with a long incubation period. The Medical journal of Australia 1992. link 44 Perrin P, Gontier C, Lecocq E, Bourhy H. A modified rapid enzyme immunoassay for the detection of rabies and rabies-related viruses: RREID-lyssa. Biologicals : journal of the International Association of Biological Standardization 1992. link80007-7) 45 Taylor M, Elkin B, Maier N, Bradley M. Observation of a polar bear with rabies. Journal of wildlife diseases 1991. link 46 Seganti L, Superti F, Sinibaldi L, Marchetti M, Bianchi S, Orsi N. Rabies virus infection in Aedes pseudoscutellaris cells: a study on receptorial structures. Comparative immunology, microbiology and infectious diseases 1991. link90007-z) 47 Pandit V, Joseph LW, Veerabhadran JS, Palaniappan C. Rapid fluorescent focus inhibition test for rabies antibody estimation using murine neuroblastoma cell line. The Indian journal of medical research 1991. link 48 Mebatsion T, Frost JW, Krauss H. Enzyme-linked immunosorbent assay (ELISA) using staphylococcal protein A for the measurement of rabies antibody in various species. Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B 1989. link 49 Jayakumar R, Ramadass P, Raghavan N. Comparison of enzyme immunodiagnosis with immunofluorescence for rapid diagnosis of rabies in dogs. Zentralblatt fur Bakteriologie : international journal of medical microbiology 1989. link80111-2) 50 Barton LD, Campbell JB. Measurement of rabies-specific antibodies in carnivores by an enzyme-linked immunosorbent assay. Journal of wildlife diseases 1988. link 51 Fekadu M, Greer PW, Chandler FW, Sanderlin DW. Use of the avidin-biotin peroxidase system to detect rabies antigen in formalin-fixed paraffin-embedded tissues. Journal of virological methods 1988. link90152-8) 52 Perrin P, Rollin PE, Sureau P. A rapid rabies enzyme immuno-diagnosis (RREID): a useful and simple technique for the routine diagnosis of rabies. Journal of biological standardization 1986. link90006-5) 53 Palmer DG, Ossent P, Suter MM, Ferrari E. Demonstration of rabies viral antigen in paraffin tissue sections: comparison of the immunofluorescence technique with the unlabeled antibody enzyme method. American journal of veterinary research 1985. link 54 Savy V, Atanasiu P. Rapid immunoenzymatic technique for titration of rabies antibodies IgG and IgM. Developments in biological standardization 1978. link

Incubating rabies